Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia
Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia
复制标题
DOI：
10.1007/s11524-006-9145-3
复制
发表时间：
2007-03-01
影响因子：
6.6
通讯作者：
Dolan, Kate
中科院分区：
文献类型：
--
作者：
Kimber, Jo;Dolan, Kate
射击场（SGs）是靠近毒品市场的非法街道空间，用于注射毒品。监督注射设施是低门槛的卫生服务，注射吸毒者可在监督下注射预先获得的药物。本研究描述了悉尼医学监督注射中心（MSIC）（澳大利亚第一个SIF）开业前后在悉尼国王十字区的SG使用情况。研究还考察了SG的操作和环境特征、SG使用的原因以及使用MSIC的意愿。对SG使用者（n = 31）的探索性调查、对SG使用者（n = 17）和药品工作者（n = 8）的访谈、从SGs （MSIC前后6个月）常规收集的使用过的针头数量以及MSIC就诊次数（MSIC后6个月）进行了三角测量。我们发现在研究期间有5例SGs手术。主要的运作特点是24小时运作，10澳元的入场费，30分钟的时间限制，以及性工作的双重用途。使用SG的主要原因是避开警察，不喜欢在公共场合注射，以及在过量情况下SG操作员的协助。SG用户报告使用MSIC的意愿很高。在MSIC开放后的6个月里，从SGs收集的用针数量减少了69%(41,819对12,935)，而MSIC的访问量则逐渐增加。我们得出结论，注射从SGs转移到MSIC，但SGs继续容纳注射，减少伤害的推广应保持。
Shooting galleries (SGs) are illicit off-street spaces close to drug markets used for drug injection. Supervised injecting facilities (SIFs) are low threshold health services where injecting drug users (IDUs) can inject pre-obtained drugs under supervision. This study describes SG use in Kings Cross, Sydney before and after the opening of the Sydney Medically Supervised Injecting Centre (MSIC), Australia's first SIF. Operational and environmental characteristics of SGs, reasons for SG use, and willingness to use MSIC were also examined. An exploratory survey of SG users (n = 31), interviews with SG users (n = 17), and drug workers (n = 8), and counts of used needles routinely collected from SGs (6 months before and after MSIC) and visits to the MSIC (6 months after MSIC) were triangulated. We found five SGs operated during the study period. Key operational characteristics were 24-h operation, AUS$10 entry fee, 30-min time limit, and dual use for sex work. Key reasons for SG use were to avoid police, a preference not to inject in public, and assistance from SG operators in case of overdose. SG users reported high levels of willingness to use the MSIC. The number of used needles collected from SGs decreased by 69% (41,819 vs. 12,935) in the 6 months after MSIC opened, while MSIC visits increased incrementally. We conclude that injections were transferred from SGs to the MSIC, but SGs continued to accommodate injections and harm reduction outreach should be maintained.